Consolidated Statements of Cash Flows
$ in millions
Fiscal Years Ended January 28, 2023 January 29, 2022 January 30, 2021
Operating activities
Net earnings $ 1,419 $ 2,454 $ 1,798
Adjustments to reconcile net earnings to total cash provided by operating activities:
Depreciation and amortization 918 869 839
Restructuring charges 147 (34) 254
Stock-based compensation 138 141 135
Deferred income taxes 51 14 (36)
Other, net 12 11 3
Changes in operating assets and liabilities, net of acquired assets and liabilities:
Receivables (103) 17 73
Merchandise inventories 809 (328) (435)
Other assets (21) (14) (51)
Accounts payable (1,099) (201) 1,676
Income taxes 36 (156) 173
Other liabilities (483) 479 498
Total cash provided by operating activities 1,824 3,252 4,927
Investing activities
Additions to property and equipment, net of $35, $46 and $32, respectively, of non-cash
capital expenditures (930) (737) (713)
Purchases of investments (46) (233) (620)
Sales of investments 7 66 546
Acquisitions, net of cash acquired - (468) -
Other, net 7 - (1)
Total cash used in investing activities (962) (1,372) (788)
Financing activities
Repurchase of common stock (1,014) (3,502) (312)
Issuance of common stock 16 29 28
Dividends paid (789) (688) (568)
Borrowings of debt - - 1,892
Repayments of debt (19) (133) (1,916)
Other, net - (3) -
Total cash used in financing activities (1,806) (4,297) (876)
Effect of exchange rate changes on cash (8) (3) 7
Increase (decrease) in cash, cash equivalents and restricted cash (952) (2,420) 3,270
Cash, cash equivalents and restricted cash at beginning of period 3,205 5,625 2,355
Cash, cash equivalents and restricted cash at end of period $ 2,253 $ 3,205 $ 5,625